Effect of dexmedetomidine versus lorazepam on outcome in patients with sepsis: an a priori-designed analysis of the MENDS randomized controlled trialPratik P. Pandharipande, Robert D. Sanders, Daniel Herr et al.|Critical Care|2010Cited by 417
WS19.03 Improvements in structural lung disease over 24 months in children with CF aged 6-11 on elexacaftor/tezacaftor/ivacaftor (ETI) – interim analysis using automated LungQ scoringP. McNally, H. Tiddens, K. Lester et al.|Journal of Cystic Fibrosis|2025Cited by 0